Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/6/2018
SIETES contiene 92381 citas

 
 
 1 a 20 de 4418 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Gafoor R, Booth HP, Gulliford MC. Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ 2018;361:23 de mayo. [Ref.ID 102648]
2.Enlace a cita original Cita con resumen
3.Enlace a cita original Cita con resumen
Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, Myint PK, Grossi CM, Mattishent K, Bennett K, Campbell NL, Boustani M, Robinson L, Brayne C, Matthews FE, Savva GM. Anticholinergic drugs and risk of dementia: case-control study. BMJ 2018;361:25 de abril. [Ref.ID 102571]
4.Enlace a cita original Cita con resumen
Charlton RA, Bettoli V, Bos HJ, Engeland A, Garne E, Gini R, Hansen AV, de Jong-van den Berg LTW, Jordan S, Klungsøyr K, Neville AJ, Pierini A, Puccini A, Sinclair M, Dolk DTH. The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures. Eur J Clin Pharmacol 2018;74:abril. [Ref.ID 102561]
5. Cita con resumen
Hirschler B. UK bans Sanofi epilepsy drug without pregnancy prevention plan. Reuters Health News 2018:24 de abril. [Ref.ID 102553]
8.Enlace a cita original Cita con resumen
Carey B, Gebeloff R. Many people taking antidepressants discover they cannot quit. N Y Times (Print) 2018:7 de abril. [Ref.ID 102504]
9. Cita con resumen
Rimmer A. Bring me a sunshine act: five minutes with . . . Peter Gordon. BMJ 2018;360:29 de marzo. [Ref.ID 102502]
10.Tiene citas relacionadas Cita con resumen
Summerfield D. NHS antidepressant prescribing: what do we get for £266m a year?. BMJ 2018;360:k1019. [Ref.ID 102475]
12. Cita con resumen
Jongsma HE, Gayer-Anderson C, Lasalvia A, Quattrone D, Mulé A, Szoke A, Selten J-P, Turner C, Arango C, Tamcone I, Berardt D, Tortelli A, Llorca P-M, de Haan L, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Murray RM, Rutten BP, Jones PB, Van Os J, Morgan C, Kirkbride JB, for the European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group. Treated incidence of psychotic disorders in the multinational EU-GEI study. JAMA Psychiatry 2017:6 de diciembre. [Ref.ID 102177]
14. Cita con resumen
Anónimo. UK grants sildenafil over-the-counter status. DIA Daily 2017:2. [Ref.ID 102150]
15. Cita con resumen
Samper E. La estafa de la homeopatía: en crisis. eldiario.es 2017:1. [Ref.ID 102149]
16. Cita con resumen
Poluzzi E, Diemberger I, de Ridder M, Koci A, Clo M, Oteri A, Pecchioli S, Bezemer I, Schink T, Ulrichsen SP, Boriani G, Sturkenboom MCJ, De Ponti F, Trifirò G. Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. Eur J Clin Pharmacol 2017;73:1499-510. [Ref.ID 102126]
17. Cita con resumen
Hawkes N. Statin initiation is unrelated to cardiovascular risk score, finds study.. BMJ 2017;359:j4898. [Ref.ID 102110]
18.Tiene citas relacionadas Cita con resumen
Socías ME, Wood E. Epidemic of deaths from fentanyl overdose. BMJ 2017;359:j4355. [Ref.ID 102107]
20.Tiene citas relacionadas Cita con resumen
Gieling EM, van den Ham HA, van Onzenoort H, Bos J, Kramers C, de Boer A, de Vries F, Burden AM. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study. Br J Clin Pharmacol 2017;83:1844-59. [Ref.ID 102014]
Seleccionar todas
 
 1 a 20 de 4418 siguiente >>